For this reason, we surmise that the unfavorable COVID-19 prognosis is directly correlated with plasma TIGIT levels and that anti-TIGIT monoclonal antibodies could be salutary for COVID-19 patients (Figures 4, 5). This evidence concerns the gene TIGIT and COVID-19.